|
New Nomenclature, Diagnostic Criteria: Antibody-Mediated Rejection in Heart …
Science Daily (press release) 18, 2013 — Antibody-mediated rejection of the transplanted heart is a recognized clinical complication and a major limitation to survival of patients who have undergone heart transplantation. Experts have now developed a new working formulation for … New ISHLT nomenclature and diagnostic criteria: Antibody-mediated rejection in …Medical Xpress |
'Stable but critical' Nelson Mandela responding to treatment – Times of India
AFP |
‘Stable but critical’ Nelson Mandela responding to treatment
Times of India Mandela’s former wife Winnie Madikizela-Mandela this week told a local newspaper that he remains “quite ill” and is unable to speak because of tubes being used to clear his lungs of liquid. He is using facial expressions to communicate, Madikizela … Mandela ‘stable but critical’MorungExpress Nelson Mandela very sensitive to germs, says ex-wife WinnieIndia Today Nelson Mandela remains stable but critical, informs South African governmentIBNLive Fars News Agency –Zee News all 268 news articles » |
Burkitt's Yields to Longer-Duration, Lower-Dose Chemo – Medscape
Medscape |
Burkitt’s Yields to Longer-Duration, Lower-Dose Chemo
Medscape For 19 adults with sporadic Burkitt’s lymphoma, a dose-adjusted version of the EPOCH-R (etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, and rituximab) regimen was associated with 95% progression-free survival and 100% overall … Low-intensity therapy very effective in Burkitt lymphomaOncology Nurse Advisor |
Combination Therapy For Severe Alcoholic Hepatitis Does Not Result in … – Toronto NewsFIX
Combination Therapy For Severe Alcoholic Hepatitis Does Not Result in …Toronto NewsFIXFour weeks of treatment with a combination of the drug pentoxifylline and the corticosteroid prednisolone did not improve 6-month survival compared with prednisolon…
Two Drugs Do Not Improve Kidney Function in Acute Heart Failure Patients – Science Daily (press release)
|
Two Drugs Do Not Improve Kidney Function in Acute Heart Failure Patients
Science Daily (press release) 18, 2013 — Two drugs tested in a larger trial did not improve kidney function in acute heart failure patients, contrary to results of smaller studies. The results were presented today at the American Heart Association’s Scientific Sessions 2013 in … Two drugs didn’t improve kidney function in acute heart failureHealthCanal.com |
AP IMPACT: Lungs don't die when you do, so study seeks donors who die … – Ottawa Citizen
Ottawa Citizen |
AP IMPACT: Lungs don’t die when you do, so study seeks donors who die …
Ottawa Citizen “We’ve had a number of very disgruntled family members that wanted to donate (a loved one’s organs) and weren’t able to,” said Dr. Jeffrey Punch, transplant surgery chief at the University of Michigan. Spurred by that family reaction, in a few months … |
Mandela 'stable but critical' – MorungExpress
South African Broadcasting Corporation |
Mandela ‘stable but critical’
MorungExpress The 95-year-old was discharged on September 1 to receive intensive care at home, after nearly three months in hospital for a lung infection. The government has refused to give details about his condition, citing the need for privacy, but said “he … Nelson Mandela very sensitive to germs, says ex-wife WinnieIndia Today Nelson Mandela still critical but stable: PresidencyZee News Mandela still critical but stable: Presidencyindiatvnews.com IBNLive –Malaysia Sun all 342 news articles » |
Two Drugs do not Improve Kidney Function in Acute Heart Failure Patients – Newswise (press release)
MedscapeTwo Drugs do not Improve Kidney Function in Acute Heart Failure PatientsNewswise (press release)EMBARGOED: Hold for release until Monday, Nov. 18, 2013, 11:45 a.m. ET, American Heart Association Scientific Sessions, Journal of the American Medi…
'Patiënten met Hepatitis B niet behandelen met rituximab' – NierNieuws.nl
NierNieuws.nl |
‘Patiënten met Hepatitis B niet behandelen met rituximab‘
NierNieuws.nl Alle patiënten moeten voor de start van een behandeling met rituximab (MabThera) gescreend worden op het hepatitis B-virus (HBV). Patiënten met een actieve hepatitis B-infectie dienen niet behandeld te worden met rituximab. Aanbevolen wordt ook om … |
Gilead's Vitekta Gets Approval in European Union – Wall Street Journal
|
Gilead’s Vitekta Gets Approval in European Union
Wall Street Journal Meanwhile, Gilead said its Phase 3 study of idelalisib in combination with rituximab in previously treated chronic lymphocytic leukemia patients who weren’t fit for chemotherapy was accepted for presentation at the Annual Meeting of the American … |
